{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:42:56Z","timestamp":1787236976322,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.urolonc.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T01:43:28Z","timestamp":1584668608000},"page":"684.e1-684.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preoperative chronic kidney disease predicts poor prognosis in patients with primary non\u2013muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor"],"prefix":"10.1016","volume":"38","author":[{"given":"Naoki","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Momota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tobisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-407X","authenticated-orcid":false,"given":"Tohru","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.02.001_bib0001","doi-asserted-by":"crossref","DOI":"10.1111\/iju.14082","article-title":"Predictive biomarkers for drug response in bladder cancer","author":"Yoshida","year":"2019","journal-title":"Int J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.02.001_bib0002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.02.001_bib0003","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.juro.2017.01.086","article-title":"Efficacy of bacillus Calmette-Gu\u00e9rin strains for treatment of nonmuscle invasive bladder cancer: a systematic review and network meta-analysis","volume":"198","author":"Boehm","year":"2017","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.02.001_bib0004","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.juro.2018.06.019","article-title":"Can we improve nonmuscle invasive bladder cancer guideline adherence with smarter risk stratification?","volume":"200","author":"Downs","year":"2018","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.02.001_bib0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/iju.13509","article-title":"Prediction models for progression of non-muscle-invasive bladder cancer: a review","volume":"25","author":"Fujii","year":"2018","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.02.001_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/iju.13410","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin instillation in non-muscle-invasive bladder cancer: a review","volume":"25","author":"Saluja","year":"2018","journal-title":"Int J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.02.001_bib0007","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.02.001_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma In Situ)\u20142019 update","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.02.001_bib0009","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clgc.2015.09.005","article-title":"EORTC risk model to predict progression in patients with non-muscle-invasive bladder cancer: is it safe to use in clinical practice?","volume":"14","author":"Busato Junior","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2020.02.001_bib0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1442-2042.2011.02845.x","article-title":"Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: a retrospective cohort study","volume":"18","author":"Hwang","year":"2011","journal-title":"Int J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.02.001_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/bju.13904","article-title":"Reduced estimated glomerular filtration rate (eGFR <60 mL\/min\/1.73 m2) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression","volume":"120","author":"Blute","year":"2017","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2020.02.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149544","article-title":"Renal function outcomes and risk factors for stage 3B chronic kidney disease after urinary diversion in patients with muscle invasive bladder cancer [corrected]","volume":"11","author":"Hatakeyama","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.02.001_bib0013","doi-asserted-by":"crossref","first-page":"35214","DOI":"10.1038\/srep35214","article-title":"Prognostic value of pre-operative renal insufficiency in urothelial carcinoma: a systematic review and meta-analysis","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2020.02.001_bib0014","article-title":"The impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma","author":"Momota","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"47","key":"10.1016\/j.urolonc.2020.02.001_bib0015","doi-asserted-by":"crossref","first-page":"83183","DOI":"10.18632\/oncotarget.20554","article-title":"Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma","volume":"8","author":"Kodama","year":"2017","journal-title":"Oncotarget"},{"issue":"37","key":"10.1016\/j.urolonc.2020.02.001_bib0016","doi-asserted-by":"crossref","first-page":"61404","DOI":"10.18632\/oncotarget.18248","article-title":"Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer","volume":"8","author":"Hamano","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.urolonc.2020.02.001_bib0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/iju.13389","article-title":"Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer","volume":"24","author":"Kobatake","year":"2017","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2020.02.001_bib0018","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.urolonc.2020.02.001_bib0019","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.urolonc.2020.02.001_bib0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11255-016-1264-5","article-title":"Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer","volume":"48","author":"Li","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.urolonc.2020.02.001_bib0021","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ndt\/gfu401","article-title":"Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health records","volume":"30","author":"McDonald","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"9889","key":"10.1016\/j.urolonc.2020.02.001_bib0022","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.urolonc.2020.02.001_bib0023","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.urolonc.2020.02.001_bib0024","doi-asserted-by":"crossref","first-page":"483.e17","DOI":"10.1016\/j.urolonc.2016.05.013","article-title":"Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer","volume":"34","author":"Mbeutcha","year":"2016","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.02.001_bib0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/0886022X.2019.1595645","article-title":"High neutrophil\/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease","volume":"41","author":"Yoshitomi","year":"2019","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.urolonc.2020.02.001_bib0026","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.urolonc.2020.02.001_bib0027","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.urolonc.2020.02.001_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3592042","article-title":"DNA damage in chronic kidney disease: evaluation of clinical biomarkers","volume":"2016","author":"Schupp","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.urolonc.2020.02.001_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2013.07.008","article-title":"Reduced estimated GFR and cancer mortality","volume":"63","author":"Iff","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.urolonc.2020.02.001_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality","volume":"33","author":"Na","year":"2011","journal-title":"Am J Nephrol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:40Z","timestamp":1761041920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920300429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1078143920300429"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative chronic kidney disease predicts poor prognosis in patients with primary non\u2013muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}